New treatment to overpower drug resistance in ovarian cancer
Monday, November 15, 2010 - 11:30
in Health & Medicine
A new treatment kills ovarian cancer cells in a way that can break the resistance mechanism -- even in those resistant to cisplatin. Researchers found the drug (FTY720) had a potent effect in human ovarian cancer cells, even in those resistant to cisplatin, the most commonly used chemotherapeutic drug currently available for the treatment of ovarian cancer.